Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced that its research has been featured on the cover of RSC Sustainability, ...

Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced a breakthrough advancement in its proprietary enzyme development ...

Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, ...

The research findings were featured on the cover of Nature Catalysis and highlighted in Nature, as well as in collections in Nature Chemical Engineering in 2022 and 2023. A joint research team, led by ...

SAN DIEGO, CA - April 11, 2025 (NEWMEDIAWIRE) - Quantumzyme Corporation (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is exploring innovative solutions in ...

SAN DIEGO, CA - November 11, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTCQB: QTZM), a global leader in computational enzyme engineering and digital biocatalysis, today announced the expansion of its ...

Fructooligosaccharides (FOS) are functional, low-calorie carbohydrates renowned for their prebiotic properties and widespread applicability in the food and pharmaceutical industries. Current ...

α-Synuclein modulates neurite outgrowth as seen here in human cells, potentially suggesting involvement of the protein in learning processes of the brain. However, dysregulated α-Synuclein leads to ...